Company / Goodwill
Edwards Lifesciences Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$1.8B
FY2025
5-year range
$1.2B / $1.8B
FY2021-FY2025
Trend
-0.5%
vs FY2024
Sector context
#45 of 136
Health Care
What the data says
At $1.8B, Edwards Lifesciences's goodwill ranks #45 of 136 in the Health Care sector. Goodwill has fluctuated over the past 10 years, ranging from $626M in FY2016 to $1.8B in FY2024.
Based on SEC 10-K filings.
$1.8B in FY2025 with a 5-year CAGR of +8.6%.
Improved from $1.2B to $1.8B over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +15.0%
- 5-Year CAGR
- +8.6%
- 10-Year CAGR
- -
Sector benchmark
#45 of 136 in Health CareTop 33% of 136This company $1.8B Sector average $5.2B
▼
-66.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.6%, indicating consistent growth.
- In FY2025, goodwill decreased 0.5% year-over-year.
- Ranks #45 out of 136 companies in the Health Care sector.
- Peak goodwill was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.8B | -0.5% |
| FY2024 | $1.8B | +52.6% |
| FY2023 | $1.2B | +0.0% |
| FY2022 | $1.2B | -0.3% |
| FY2021 | $1.2B | -0.5% |
| FY2020 | $1.2B | +0.5% |
| FY2019 | $1.2B | +5.0% |
| FY2018 | $1.1B | -1.3% |
| FY2017 | $1.1B | +79.9% |
| FY2016 | $626.1M | -0.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026